Sky Women's Health

Carolyn Moyers
  • 5.0 (27)
  • HEALTH & FITNESS
  • UPDATED WEEKLY

Join Dr. Carolyn Moyers, a Board Certified OBGYN, as she dives deeper into important women's health topics, and interviews experts in the field. Founder of Sky Women's Health in Fort Worth, Texas, Dr. Moyers is fellowship trained in neuromusculoskeletal medicine and a menopause society certified provider. She specializes in perimenopause, menopause, pelvic pain, and sexual medicine. In this podcast, she shares her knowledge and experience in women's health with a focus on empowering women to take control of their health and wellness.

  1. 2D AGO

    Episode 233: At-Home HPV Testing: Promise or Peril in a New Screening Era

    At-home HPV testing has been approved by the FDA and is being widely marketed as a breakthrough in cervical cancer screening—offering convenience, privacy, and accessibility. But as enthusiasm grows, so do important questions. Can at-home HPV testing truly replace the Pap test? What cancers might be missed? And how should women and clinicians thoughtfully integrate this new option into evidence-based care? In this episode of Sky Women’s Health, Dr. Carolyn Moyers talks with Dr. Richard Hopley, pathologist and Director of Clinical Pathology at PathAdvantage, to unpack what the headlines aren’t telling you about FDA-approved at-home HPV tests. We discuss why HPV-only testing sounds appealing, what it does well, and where it falls short—especially when used as a replacement for the Pap test. Why This Matters to You * HPV testing alone can miss some cervical cancers—even with a negative result * Certain at-home tests detect transient infections, increasing anxiety and unnecessary procedures * The Pap test still provides critical information HPV tests cannot * Convenience should never come at the cost of missed or delayed diagnoses What You’ll Learn * Who at-home HPV testing may help—and who it may not * Why many experts still recommend Pap + HPV co-testing * How to interpret HPV results without panic * How to make informed screening decisions that prioritize long-term health Bottom line: At-home HPV testing may expand access, but it does not replace comprehensive gynecologic care. Knowing the limits of new technology helps you protect your health—without relying on headlines alone. https://www.pathadvantage.com/at-home-hpv-testing-promise-or-peril/ 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: @drcarolynmoyers 🌐 Website: www.skywomenshealth.com

    36 min

  2. DEC 14

    Episode 232: Perimenopause and Estrogen Therapy: Dr. Rachel Pope on Why Headlines Aren’t the Whole Story

    If you felt whiplash reading recent headlines about estrogen and perimenopause—you’re not alone. At the 2025 Menopause Society Annual Meeting, a research poster analyzing data from more than 120 million women unexpectedly ignited a media firestorm. News outlets quickly framed the findings as proof that starting estrogen in perimenopause prevents breast cancer, heart attacks, and stroke—sparking viral conversations that went far beyond what the data can actually support. In this episode of Sky Women’s Health, Dr. Carolyn Moyers is joined by Dr. Rachel Pope, MD, gynecologist, menopause specialist, and mentor on the research team behind the poster, to slow the conversation down and bring clarity back to the science. Together, we unpack what the study really showed, what was lost in translation, and how women should interpret this information when making decisions about hormone therapy. Why This Study Caught Fire * The study used a massive electronic health record database of over 120 million patient records * It compared women who started estrogen: * during perimenopause * after menopause * or never used estrogen * It examined rates of breast cancer, heart attack, and stroke * Media headlines quickly implied causation—despite this being a retrospective, observational study What the Data Actually Showed * Women who used estrogen during perimenopause (within 10 years before menopause) did not have higher rates of breast cancer, heart attack, or stroke compared with the other groups * These findings support the idea that earlier initiation may be safe and potentially beneficial—but do not prove protection or prevention * The results align with the broader timing hypothesis of hormone therapy, but do not settle the debate Critical Limitations That Didn’t Make the Headlines * This study relied on diagnosis codes, not individual chart review * It did not analyze: * type of estrogen * dose or route * type of progestin * There was no breakdown by race, ethnicity, or other demographic factors * Because perimenopausal women are younger, some conditions (like breast cancer or cardiovascular disease) may simply not have occurred yet during the study’s timeframe * Like all retrospective studies, it cannot determine cause and effect Why This Still Matters for Women * Many women experience significant symptoms during perimenopause, often years before their final period * Hormone therapy can be life-changing for symptoms and quality of life * This study helps normalize thoughtful, earlier conversations—but it does not replace individualized medical decision-making * Observational data like this helps generate hypotheses and funding for future prospective trials, which we still urgently need The Real Takeaway This study doesn’t mean everyone should start estrogen in perimenopause—and it doesn’t mean estrogen prevents disease. What it does mean is that earlier use appears reassuringly safe in this dataset, and that women deserve nuanced, evidence-based counseling rather than fear-driven or headline-driven decisions. If you’re navigating perimenopause, the most important factors remain: * your symptoms * your health history * your goals * your personal risk profile * shared decision-making with a menopause-informed clinician Resources Mentioned * The Menopause Society provider directory at Menopause.org for finding evidence-based menopause care 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: a href="https://www.youtube.com/@drcarolynmoyers" rel="noopener noreferrer"...

    29 min

  3. NOV 30

    Episode 231: Can I Use Local Vaginal Estrogen AND Systemic Hormone Therapy?

    Can you use vaginal estrogen and systemic hormone therapy? Absolutely — and most women actually need both. If you’re still experiencing: • dryness or burning • painful sex • tearing when you wipe • urinary urgency/frequency • recurrent UTIs …it’s not you, and it’s not that your hormones “aren’t working.” It’s that systemic estrogen doesn’t fully treat Genitourinary Syndrome of Menopause (GSM). Here’s what the research shows: ✔ Up to 84% of women experience GSM ✔ 20–30% of women on systemic HT still need vaginal estrogen ✔ 50–70% benefit from using both Local vaginal therapy directly restores the vulvar and vaginal tissue. You deserve comfort, pleasure, and confidence again. Relief is absolutely possible. 👉 Listen to this episode to learn the exact treatment options available and why they work. 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: @drcarolynmoyers 🌐 Website: www.skywomenshealth.com

    19 min

  4. NOV 23

    Episode 230: What No One Prepared Women For After Breast Cancer — And Why It Matters

    Meet the researcher who brought a room of sexual medicine experts to their feet. This week on Sky Women’s Health, I’m talking with Dr. Janeane Anderson — one of the most compelling voices in sexual health equity, breast cancer survivorship, and patient-clinician communication. We dive into: ✨ The sexual symptoms women experience during endocrine therapy ✨ Why so many women suffer in silence ✨ How communication profoundly affects treatment adherence ✨ Racial disparities in quality-of-life and cancer outcomes ✨ What clinicians can do TODAY to change the experience for patients ✨ How patients can advocate for themselves in the exam room If you care about women’s health, survivorship, and truly patient-centered care — this episode will move you. #breastcancersurvivor #sexualhealth #womenshealthmatters #menopausedoctor #patientexperience #shareddecisionmaking #isswsh #oncologycare #womenshealthresearch #skywomenshealth 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: @drcarolynmoyers 🌐 Website: www.skywomenshealth.com

    53 min

  5. NOV 16

    Episode 229: FDA Removes Black Box Warning on Estrogen: What Women Need to Know Now

    THE FDA FINALLY REMOVED THE BLACK BOX WARNING on both systemic estrogen and low-dose vaginal estrogen — and it’s one of the biggest wins in women’s health in decades. For years, millions of women avoided hormone therapy because of outdated, frightening warnings that did NOT match the scientific evidence. This led to unnecessary suffering — from painful sex to recurrent UTIs to fear-based avoidance of safe, effective treatments. In this episode, Dr. Carolyn Moyers (Board-Certified OB/GYN + Menopause Specialist) breaks down the NEW FDA labeling, the real data on hormone therapy safety, and why vaginal estrogen is one of the safest and most life-changing treatments in menopause care. 🔥 WHAT YOU’LL LEARN Why the FDA removed the black box warning for vaginal estrogen and systemic estrogen The real evidence about cancer, heart attack, stroke, and blood clot risk Why low-dose vaginal estrogen is safe — even for people afraid of hormones How vaginal estrogen improves lubrication, painful sex, and satisfaction How it reduces urinary urgency, frequency, leakage, and prevents UTIs, sepsis, and hospitalization The harms caused by fear-based avoidance of hormone therapy Patient stories that illustrate how badly this update was needed 🔍 WHO THIS EPISODE FOR Women in perimenopause or postmenopause Anyone suffering from GSM, vaginal dryness, or recurrent UTIs Partners who want to support their loved one Clinicians seeking clarity on the new estrogen labeling Anyone confused (or scared!) about hormone therapy 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: @drcarolynmoyers 🌐 Website: www.skywomenshealth.com

    14 min

  6. NOV 9

    Episode 228: When Your Ovaries Stop Too Soon: Premature Ovarian Insufficiency Explained

    Premature Ovarian Insufficiency (POI) is more than early menopause—it’s a condition that impacts the heart, bones, brain, and overall wellbeing. In this episode, Dr. Carolyn Moyers sits down with Dr. Esra Shermadou, family medicine and obesity medicine physician, to unpack what POI really means for women’s health. Dr. Shermadou shares her personal journey with POI and how it shaped her mission to help women reclaim their energy and confidence through hormone therapy, lifestyle strategies, and compassionate, root-cause care. They discuss: The difference between POI and natural menopause Key health risks and why early diagnosis matters Hormone and non-hormonal treatment options Fertility, emotional health, and empowerment If you or someone you love has faced POI—or you simply want to understand women’s hormones on a deeper level—this conversation is full of wisdom, hope, and practical tools to help you thrive. 🔗 Connect with Dr. Esra Shermadou YouTube: https://youtube.com/@dresrashermadou?si=p9-CL296eS1r59Pz Facebook: https://www.facebook.com/share/1BnQxmfsmV/?mibextid=wwXIfr Instagram: @dresra_shermadou_do AND @dresrasgottheiron TikTok: @dr_esra_shermadou Website: SakinahHealth.com Blog: https://www.drshermadou.com 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: @drcarolynmoyers 🌐 Website: www.skywomenshealth.com

    33 min

  7. NOV 2

    Episode 227: The Truth About Modern Menopausal Hormone Therapy

    Menopausal hormone therapy (MHT) has evolved dramatically since the early 2000s, yet many women still carry outdated fears and misinformation. In this episode, Dr. Carolyn Moyers breaks down the key insights from Dr. Barbara Levy and Dr. James Simon’s “A Contemporary View of Menopausal Hormone Therapy” — clarifying what today’s evidence really shows about safety, timing, and individualization of care. You’ll learn: Why hormone therapy remains the most effective treatment for hot flashes, sleep disruption, and vaginal symptoms How the timing of initiation affects risks and benefits The differences between oral and transdermal estrogen options The vital role of progestogens for women with a uterus How modern guidance supports a personalized approach, not a one-size-fits-all model Mentioned in this episode: A Contemporary View of Menopausal Hormone Therapy, Dr. Barbara Levy & Dr. James Simon, Menopause Journal (2025) The Menopause Society — www.menopause.org 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: @drcarolynmoyers 🌐 Website: www.skywomenshealth.com

    28 min

  8. OCT 26

    Episode 226: Progesterone: What is it good for? Understanding Progestogens in Menopause

    Progesterone often gets less attention than estrogen, but it plays a powerful role in women’s health — especially during menopause. When we talk about progestogens, that includes both natural progesterone and synthetic forms called progestins. Their main job is to protect the uterine lining when estrogen is used, but progesterone offers additional benefits worth knowing. In this episode, Dr. Carolyn Moyers breaks down: Why progesterone is essential for women with a uterus on estrogen therapy The difference between natural progesterone and progestins How progesterone can support sleep, mood, heart, and bone health Why the type and route of hormone therapy matter Get the facts on what progesterone is really good for — and how it fits into a modern, personalized approach to menopause care. 🔗 Connect with Dr. Carolyn Moyers 📸 Instagram: @drcarolynmoyers 🎥 YouTube: @drcarolynmoyers 🌐 Website: www.skywomenshealth.com Mentioned in this episode: Menopause Journal, October 2025, Liu JH. “Role of progestogens in hormone therapy"

    16 min
See All (234)

Trailer

5
out of 5
27 Ratings

About

Join Dr. Carolyn Moyers, a Board Certified OBGYN, as she dives deeper into important women's health topics, and interviews experts in the field. Founder of Sky Women's Health in Fort Worth, Texas, Dr. Moyers is fellowship trained in neuromusculoskeletal medicine and a menopause society certified provider. She specializes in perimenopause, menopause, pelvic pain, and sexual medicine. In this podcast, she shares her knowledge and experience in women's health with a focus on empowering women to take control of their health and wellness.

Information

  • Creator
    Carolyn Moyers
  • Years Active
    2020 - 2025
  • Episodes
    234
  • Rating
    Explicit
  • Copyright
    © Carolyn Moyers, DO, FACOG, MSCP, IF
  • Show Website
    Sky Women's Health

You Might Also Like